Drugs & Side Effects |

Tequin News

Tequin Maker Sued in Canada

RSS News Feeds
Drugs & Pharmacuticals
Silica Dust
Tequin
 All RSS Feeds

At a glance:

A class-action lawsuit has been launched in Canada against Bristol-Myers Squibb over the antibiotic drug Tequin (gatifloxacin). 
 
The drug was commonly used to treat conditions such as pneumonia, bronchitis, and skin and urinary tract infections. Problems became known three years ago when some patients developed serious side effects which required additional health care and in some cases were life-altering.  
 
Tequin interferes with sugar metabolism even in non-diabetics, and the drug maker previous announced plans to discontinue it. 
 
The lawsuit alleges however that the risks were known years ago and that Bristol-Myers Squibb failed to warn both doctors and patients. 
 
In the US, the FDA has ordered increased warnings on the drug's label.

Tequin drugmaker named in class-action lawsuit

CTV.ca - 5/8/2006 10:26 PM

A $200,000 class-action lawsuit has been launched against Bristol-Myers Squibb, alleging the drugmaker failed in its duty to warn patients of the risks associated with commonly prescribed antibiotic.
 
The lawsuit argues that the drugmaker failed to properly apprise one of the plaintiffs, Alban Conlon, as well as physicians in Canada of risks associated with Tequin.
 

 
· Read The Full Tequin Article From CTV.ca -->

· Read All Tequin (Gatifloxacin) News Stories -->

Comments On Tequin News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: